Metallic nanoparticle-based options for glioblastoma treatment

Financiador

Organização

Publicações

An update of advanced nanoplatforms for Glioblastoma Multiforme Management

Publication . Amaral, Mariana; Cruz, Nuno; Ana Rosa; Nogueira, Beatriz; Costa, Diana; Santos, Francisco; Brazão, Mariana; Policarpo, Pedro; Mateus, Rita; Kobozev, Yan; Reis, Catarina Pinto

Glioblastoma multiforme (GBM) is a very aggressive and heterogeneous glioma. Currently, GBM is treated with a combination of surgery, radiotherapy, chemotherapy (e.g. temozolamide) and Tumour Treating Fields. Unfortunately, the mean survival is still around 15 months. This poor prognosis is associated with therapy resistance, tumor recurrence, and limited delivery of drugs due to the blood-brain barrier nature. Nanomedicine, the application of nanotechnology to medicine, has revolutionized many health fields, specifically cancer diagnosis and treatment. This review explores the particularities of different nanosystems (i.e., superparamagnetic, polymeric and gold nanoparticles, and liposomes) as well as how they can be applied to the treatment and diagnosis of GBM. As described, the most of the cited examples are on the preclinical phase; however, positive results were obtained and thus, the distance to achieve an effective treatment is shorter every day.

2021-11-15Artigo científico

Acesso aberto

Ver mais

Entidade financiadora

Fundação para a Ciência e a Tecnologia

Programa de financiamento

OE

Número da atribuição

UI/BD/150754/2020